Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. [electronic resource]
Producer: 20200710Description: 1334-1345.e5 p. digitalISSN:- 1528-0012
- Aged
- Biopsy
- Blood Proteins
- Double-Blind Method
- Drug Administration Schedule
- Female
- Galectin 3 -- antagonists & inhibitors
- Galectins
- Humans
- Hypertension, Portal -- diagnosis
- Infusions, Intravenous
- Liver -- drug effects
- Liver Cirrhosis -- diagnosis
- Male
- Middle Aged
- Non-alcoholic Fatty Liver Disease -- complications
- Pectins -- administration & dosage
- Placebos -- administration & dosage
- Portal Pressure -- drug effects
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.